These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28625362)

  • 1. Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-II.
    Strack M; Billard É; Chatenet D; Lubell WD
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3412-3416. PubMed ID: 28625362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity.
    Merlino F; Yousif AM; Billard É; Dufour-Gallant J; Turcotte S; Grieco P; Chatenet D; Lubell WD
    J Med Chem; 2016 May; 59(10):4740-52. PubMed ID: 27140209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics.
    Wei X; Diarra S; Douchez A; Cunico Dallagnol JC; Hébert TE; Chatenet D; Lubell WD
    J Med Chem; 2023 Oct; 66(20):14241-14262. PubMed ID: 37800680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.
    Carotenuto A; Auriemma L; Merlino F; Limatola A; Campiglia P; Gomez-Monterrey I; di Villa Bianca Rd; Brancaccio D; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
    J Pept Sci; 2013 May; 19(5):293-300. PubMed ID: 23526702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda.
    Conlon JM; O'Harte F; Smith DD; Tonon MC; Vaudry H
    Biochem Biophys Res Commun; 1992 Oct; 188(2):578-83. PubMed ID: 1445302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.
    Billard E; Hébert TE; Chatenet D
    J Med Chem; 2018 Oct; 61(19):8707-8716. PubMed ID: 30183282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one γ-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex Vivo.
    Dufour-Gallant J; Chatenet D; Lubell WD
    J Med Chem; 2015 Jun; 58(11):4624-37. PubMed ID: 25984647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation and Dynamics of Human Urotensin II and Urotensin Related Peptide in Aqueous Solution.
    Haensele E; Mele N; Miljak M; Read CM; Whitley DC; Banting L; Delépée C; Sopkova-de Oliveira Santos J; Lepailleur A; Bureau R; Essex JW; Clark T
    J Chem Inf Model; 2017 Feb; 57(2):298-310. PubMed ID: 28055189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
    Billard E; Létourneau M; Hébert TE; Chatenet D
    Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics.
    Douchez A; Billard E; Hébert TE; Chatenet D; Lubell WD
    J Med Chem; 2017 Dec; 60(23):9838-9859. PubMed ID: 29131958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
    Carotenuto A; Auriemma L; Merlino F; Yousif AM; Marasco D; Limatola A; Campiglia P; Gomez-Monterrey I; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
    J Med Chem; 2014 Jul; 57(14):5965-74. PubMed ID: 24992374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.
    Chatenet D; Folch B; Feytens D; Létourneau M; Tourwé D; Doucet N; Fournier A
    J Med Chem; 2013 Dec; 56(23):9612-22. PubMed ID: 24251366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
    Grieco P; Carotenuto A; Patacchini R; Maggi CA; Novellino E; Rovero P
    Bioorg Med Chem; 2002 Dec; 10(12):3731-9. PubMed ID: 12413830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction.
    Labarrère P; Chatenet D; Leprince J; Marionneau C; Loirand G; Tonon MC; Dubessy C; Scalbert E; Pfeiffer B; Renard P; Calas B; Pacaud P; Vaudry H
    J Enzyme Inhib Med Chem; 2003 Apr; 18(2):77-88. PubMed ID: 12943190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.
    Jarry M; Diallo M; Lecointre C; Desrues L; Tokay T; Chatenet D; Leprince J; Rossi O; Vaudry H; Tonon MC; Prézeau L; Castel H; Gandolfo P
    Biochem J; 2010 Apr; 428(1):113-24. PubMed ID: 20192922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convergent synthesis of new beta-turn mimics by click chemistry.
    Oh K; Guan Z
    Chem Commun (Camb); 2006 Aug; (29):3069-71. PubMed ID: 16855688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URP.
    Lescot E; Sopkova-de Oliveira Santos J; Dubessy C; Oulyadi H; Lesnard A; Vaudry H; Bureau R; Rault S
    J Chem Inf Model; 2007; 47(2):602-12. PubMed ID: 17381176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.
    Brancaccio D; Merlino F; Limatola A; Yousif AM; Gomez-Monterrey I; Campiglia P; Novellino E; Grieco P; Carotenuto A
    J Pept Sci; 2015 May; 21(5):392-9. PubMed ID: 25694247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.